Global Patient Engagement Solutions Market

Description

Market Overview

Patient Engagement Solutions Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 20.43% during the forecast period (2022-2029).

Patient engagement solutions enable patients to manage their healthcare information better and interact with the medical team. It is critical to actively provide the tools required to improve the patient's health management. Patients can aid in efficient self-care by having quick and easy access to healthcare professionals and personal healthcare information.

Market Dynamics

Adoption of Government Policies and Programs that Promote Patient-Centered Care is expected to drive market growth.

In March 2020, the IS President signed the CARES (Coronavirus Aid, Relief, and Economic Security) Act, a USD 2 million coronavirus emergency stimulus program. The bill expands coverage for therapy and assistance for persons affected by COVID-19. The CARES Act also increases Medicare payments for telehealth services, allows physician nurse specialists to be certified by Medicare for home health services, and increases Medicare payments for hospital stays associated with COVID-19 and durable medical equipment. As a result of such activities and regulations, the demand for and acceptability of patient engagement solutions in significant global markets is likely to rise. Moreover, increasing implementation of mhealth and the growing occurrence of chronic diseases, enhanced healthcare services, patient literacy, and patient tracking information is also boosting the market's growth.

Restraint:

Large investment requirements for healthcare infrastructure and high implementation costs for healthcare IT systems are the factors the market is expected to hamper the market growth in the forecast period.

Industry Analysis

The patient engagement solutions market provides in-depth analysis of the market based on various industry factors such as porter five forces, supply chain, pricing analysis etc.

Segment Analysis

Software segment is expected to hold the largest market share in patient engagement solutions market.

The software segment accounted for the largest market share in 2021. The segment benefits because software is simple to set up and use and makes obtaining precise drug information easier. It also facilitates the effective digital transfer of medications. Patient interaction software is used in several businesses, including home healthcare and healthcare management. For instance, Allscripts' MyHealth is a popular mobile-first, flexible enterprise patient engagement system. Physicians, hospitals, and health systems use it to increase patient happiness and treatment quality. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global patient engagement solutions market

North America accounted for the largest market share in 2021. The increasing adoption of mhealth and electronic health records (EHR), increased investment in patient engagement software, rising public awareness combined with increased government funding in the healthcare industry, and product launches and acquisitions by market players are the factors the market is driven in the forecast period. For instance, In January 2022, Ashfielf Engage announced the acquisition of Medaxis, a company that provides healthcare professionals and patients with patient engagement services. In addition, the firm is adding 40 Medaxis employees to its workforce in Canada. Ashfield Engage and Medaxis have already collaborated on several projects, and the strategic partnership will allow Ashfield Engage to provide tailored solutions to customers across the country. Moreover, chronic illnesses are the biggest cause of disability and mortality in the United States, according to the Centers for Disease Control and Prevention (CDC), and the largest contributor to the country's USD 3.8 trillion annual healthcare costs. The COVID-19 outbreak has made digital solutions vital in the worldwide market, in addition to emphasizing the significance of remote care. Thus, from the above statements, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the patient engagement solutions market are Allscripts Healthcare Solutions, Inc, Athenahealth, Inc, Cerner Corporation, McKesson Corporation, Phytel, Inc, Orion Health Ltd, Lincor Solutions Ltd, GetWellNetwork, Inc, YourCareUniverse, Inc, MEDecision, Inc.

Allscripts Healthcare Solutions, Inc.:

Overview:

Allscripts Healthcare Solutions Inc (Allscripts) is a healthcare information technology solutions provider. The company's core solutions include Electronic Health Records (EHR), financial management solutions, population health management solutions, and consumer solutions to assist its clients. The company also provides consultancy, managed IT services, education, hardware, and hosting services. Allscripts, Allscripts TouchWorks, Allscripts Professional HER, Veradigm, and FollowMyHealth are among its prominent brands. Allscripts services retail pharmacies, pharmacy benefit managers, physicians, hospitals, governments, health systems, health plans, retail clinics, and post-acute organizations in North America, Asia, Australia, the Middle East, and the United Kingdom.

Product Portfolio:

FollowMyHealth: FollowMyHealth is a mobile-first, enterprise patient engagement solution for providers, hospitals and health systems that would like to promote healthy patient populations and manage quality.

The global patient engagement solutions market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Product Code: DMHCIT1717

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Market Snippet by Product component
3.2. Market Snippet by Mode of Delivery
3.3. Market Snippet by Application
3.4. Market Snippet by End-user
3.5. Market Snippet by Therapeutic Area

4. Dynamics

4.1. Market Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The rise in the aging population
  - 4.1.1.2. The increasing burden of chronic diseases
  - 4.1.1.3. The rise in the focus of patients on self-managing their care
- 4.1.2. Restraints
  - 4.1.2.1. Concerns related to the security of patient data
  - 4.1.2.2. The lack of interoperability
- 4.1.3. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis

6. By Product component

6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
6.3. Market Attractiveness Index, By Product component
- 6.3.1. Hardware *
  - 6.3.1.1. Introduction
  - 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
- 6.3.2. Software
  - 6.3.2.1. Standalone Solutions
  - 6.3.2.2. Integrated Solutions
- 6.3.3. Services
  - 6.3.3.1. Consulting Services
  - 6.3.3.2. Implementation Services
  - 6.3.3.3. Training & Education Services
  - 6.3.3.4. Post-sale & Maintenance Services
  - 6.3.3.5. Advertising Services
  - 6.3.3.6. Enrollment Services

7. By Mode of Delivery

7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
7.3. Market Attractiveness Index, By Mode of Delivery
- 7.3.1. On-Premise *
  - 7.3.1.1. Introduction
  - 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
- 7.3.2. Web-based
- 7.3.3. Cloud-based

8. By Application

8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.3. Market Attractiveness Index, By Application
- 8.3.1. Health Management *
  - 8.3.1.1. Introduction
  - 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
- 8.3.2. Social and Behavioral Management
- 8.3.3. Home Health Management
- 8.3.4. Financial Health Management

9. By End-user

9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
9.3. Market Attractiveness Index, By End-user
- 9.3.1. Individual Users *
  - 9.3.1.1. Introduction
  - 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
- 9.3.2. Providers
  - 9.3.2.1. Hospitals
  - 9.3.2.2. Physicians
- 9.3.3. Payers
  - 9.3.3.1. Private
  - 9.3.3.2. Government
- 9.3.4. Other End Users

10. By Therapeutic Area

10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
10.3. Market Attractiveness Index, By Therapeutic Area
- 10.3.1. Chronic Diseases *
  - 10.3.1.1. Introduction
  - 10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2020-2027
  - 10.3.1.3. Diabetes
  - 10.3.1.4. Cardiovascular Disease
  - 10.3.1.5. Obesity (Weight Loss Management)
  - 10.3.1.6. Other Chronic Diseases
- 10.3.2. Women's Health
- 10.3.3. Fitness
- 10.3.4. Other Therapeutic Areas

11. By Region

11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
11.3. Market Attractiveness Index, By Region
11.4. North America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
- 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
- 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
- 11.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.4.8.1. The U.S.
  - 11.4.8.2. Canada
  - 11.4.8.3. Mexico
11.5. Europe
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
- 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
- 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
- 11.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.5.8.1. Germany
  - 11.5.8.2. U.K.
  - 11.5.8.3. France
  - 11.5.8.4. Italy
  - 11.5.8.5. Spain
  - 11.5.8.6. Rest of Europe
11.6. South America
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
- 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
- 11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
- 11.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.6.8.1. Brazil
  - 11.6.8.2. Argentina
  - 11.6.8.3. Rest of South America
11.7. Asia-Pacific
- 11.7.1. Introduction
- 11.7.2. Key Region-Specific Dynamics
- 11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
- 11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
- 11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area
- 11.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.7.8.1. China
  - 11.7.8.2. India
  - 11.7.8.3. Japan
  - 11.7.8.4. Australia
  - 11.7.8.5. Rest of Asia Pacific
11.8. Middle East and Africa
- 11.8.1. Introduction
- 11.8.2. Key Region-Specific Dynamics
- 11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product component
- 11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
- 11.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic Area

12. Global Market Competitive Landscape

12.1. Competitive Scenario
12.2. Comparative Product component Portfolio Analysis
12.3. Market Positioning/Share Analysis
12.4. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Allscripts Healthcare Solutions, Inc*
- 13.1.1. Company Overview
- 13.1.2. Product component Portfolio and Description
- 13.1.3. Key Highlights
- 13.1.4. Financial Overview
13.2. Athenahealth, Inc
13.3. Cerner Corporation
13.4. McKesson Corporation
13.5. Phytel, Inc
13.6. Orion Health Ltd
13.7. Lincor Solutions Ltd
13.8. GetWellNetwork, Inc
13.9. YourCareUniverse, Inc
13.10. MEDecision, Inc

14. Premium Insights

15. DataM Intelligence

15.1. Appendix
15.2. About Us and Services
15.3. Contact Us

Global Patient Engagement Solutions Market - 2022-2029